Regulatory Support
Navigating an increasingly complex global regulatory environment is one of the most demanding aspects of bringing a pharmaceutical product to market. Curia offers dedicated regulatory support services that help clients manage this complexity with confidence, drawing on deep scientific expertise and a proven track record of successful submissions from development through commercialisation.
Free Buyers Guide
Leading Guide to Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry
Thank you.
Your download email will arrive shortly. Please check your mail inbox to download the buyer's guide
You may also be interested in:
With decades of experience and more than 550 API dossiers submitted across worldwide markets, Curia’s regulatory teams maintain a strong compliance record with major health authorities, including the FDA, EMA, PMDA, ANVISA, and others.
The company provides comprehensive support across the product lifecycle, encompassing global filing strategy, CMC module authoring for both drug substance and drug product, Certificate of Suitability (CEP) preparation and maintenance, agency meeting facilitation, deficiency management, site registrations, US Agent services, and eCTD publishing. Specialised expertise is also available for controlled substances, including DEA registrations, quota and determination requests, and related consulting.
By integrating regulatory insight across small molecule and biologics programmes, Curia helps clients streamline approval pathways, reduce risk, and accelerate their route to market.
Free Buyers Guide
Leading Guide to Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry
Thank you.
Your download email will arrive shortly. Please check your mail inbox to download the buyer's guide
You may also be interested in:
